ATE169822T1 - Behandlung von herpesvirus infektion - Google Patents

Behandlung von herpesvirus infektion

Info

Publication number
ATE169822T1
ATE169822T1 AT93911414T AT93911414T ATE169822T1 AT E169822 T1 ATE169822 T1 AT E169822T1 AT 93911414 T AT93911414 T AT 93911414T AT 93911414 T AT93911414 T AT 93911414T AT E169822 T1 ATE169822 T1 AT E169822T1
Authority
AT
Austria
Prior art keywords
treatment
herpesvirus infection
herpesviruses
oligopeptide
preferred
Prior art date
Application number
AT93911414T
Other languages
English (en)
Inventor
Michael Twist
Richard W Barnett
Martin Summer-Smith
Lorne S Reid
Original Assignee
Allelix Biopharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allelix Biopharma filed Critical Allelix Biopharma
Application granted granted Critical
Publication of ATE169822T1 publication Critical patent/ATE169822T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT93911414T 1992-04-23 1993-04-21 Behandlung von herpesvirus infektion ATE169822T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87239892A 1992-04-23 1992-04-23

Publications (1)

Publication Number Publication Date
ATE169822T1 true ATE169822T1 (de) 1998-09-15

Family

ID=25359492

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93911414T ATE169822T1 (de) 1992-04-23 1993-04-21 Behandlung von herpesvirus infektion

Country Status (7)

Country Link
EP (1) EP0637247B1 (de)
JP (1) JPH08501060A (de)
AT (1) ATE169822T1 (de)
AU (1) AU4037793A (de)
CA (1) CA2134119A1 (de)
DE (1) DE69320469D1 (de)
WO (1) WO1993021941A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5633230A (en) * 1990-10-24 1997-05-27 Allelix Biopharmaceuticals, Inc. Treatment of cytomegalovirus infection
AU685862B2 (en) * 1993-10-22 1998-01-29 Allelix Biopharmaceuticals Inc. Treatment of cytomegalovirus infection
DE19520792A1 (de) * 1995-06-07 1996-12-12 Bloch Wilhelm Dr Verwendung der Stickstoffmonoxidsynthese hemmenden Substanzen der Gruppe der L-Argininanaloge zur Herstellung eines Mittels zur Abschwellung entzündlich bzw. allergisch angeschwollener Nasenschleimhaut und der Hemmung entzündlich und allergisch bedingter Nasensekretion
AU734827B2 (en) 1997-05-21 2001-06-21 Board Of Trustees Of The Leland Stanford Junior University Composition and method for enhancing transport across biological membranes
EP1656945A1 (de) * 1999-06-05 2006-05-17 The Board Of Trustees Of The Leland Stanford Junior University Pharmazeutische Zusammensetzung enthaltend Oligoarginin
US7229961B2 (en) 1999-08-24 2007-06-12 Cellgate, Inc. Compositions and methods for enhancing drug delivery across and into ocular tissues
US6669951B2 (en) 1999-08-24 2003-12-30 Cellgate, Inc. Compositions and methods for enhancing drug delivery across and into epithelial tissues
US6730293B1 (en) 1999-08-24 2004-05-04 Cellgate, Inc. Compositions and methods for treating inflammatory diseases of the skin
EP1210121A2 (de) 1999-08-24 2002-06-05 Cellgate Inc. Verbesserung der verabreichung von medikamenten durch und in epitheliale gewebe durch verwendung von oligoarginine-gruppen
US7033991B2 (en) * 2001-07-16 2006-04-25 Board Of Supervisors Of Louisiana State University And Agriculture And Mechanical College Inhibiting furin with polybasic peptides
JP5401457B2 (ja) * 2007-07-26 2014-01-29 ルバンス セラピュティックス インク． 抗菌ペプチド、組成物及びその使用方法
ES2444299B1 (es) 2012-08-23 2014-12-12 Nutrición Técnica Deportiva, S.L. Uso de un hidrolizado de caseina como agente antiherpético

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3756789A (en) * 1988-06-16 1990-01-12 St. Louis University Antagonists of viral transactivating proteins
JPH06501938A (ja) * 1990-10-24 1994-03-03 アレリックス　バイオファーマシューティカルズ　アイエヌシー． ペプチドよりなるｈｉｖ複製阻害剤

Also Published As

Publication number Publication date
CA2134119A1 (en) 1993-11-11
WO1993021941A1 (en) 1993-11-11
DE69320469D1 (de) 1998-09-24
JPH08501060A (ja) 1996-02-06
EP0637247B1 (de) 1998-08-19
AU4037793A (en) 1993-11-29
EP0637247A1 (de) 1995-02-08

Similar Documents

Publication Publication Date Title
GR3022838T3 (en) Peptide-based inhibitors of hiv replication
EA199901031A1 (ru) Производные бензимидазола
ATE169822T1 (de) Behandlung von herpesvirus infektion
ATE303993T1 (de) 4-hydroxychinolin-3-carboxamide und hydrazide als antivirale wirkstoffe
DK0973735T3 (da) Polyaromatiske antivirale præparater
NO953371D0 (no) Anvendelse av anti-konvulsiva ved behandling av neuro-AIDS
MX9308005A (es) Compuestos inhibidores de la proteasa del virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulacion farmaceutica que los contiene.
ATE201693T1 (de) Hämoregulierende peptide
EA199800526A1 (ru) Производные бензимидазола и их применение для лечения вирусных инфекций
DE69125262D1 (de) Synergische Mischung zur Behandlung von Herpes
AR005750A1 (es) Composicion farmaceutica para tratar o prevenir infecciones con zoster en personas infectadas con el virus de varicela zoster y procedimiento para preparar dicha composicion
DE69608959D1 (de) Chlamydia impfstoffen
ES2101747T3 (es) Penciclovir y famciclovir y derivados de guanina relacionados para el tratamiento de infecciones por vih-1.
DE69004451D1 (de) Prophylaxe und Behandlung von Herpesvirus-Infektionen.
DE69514928D1 (de) Gegen protozoen wirksamezyklische tetrapeptide
ITMI913493A1 (it) Dispositivo per la disinfezione o la immunizzazione di zone del corpo umano esposte al contagio, da germi, batteri e virus
UA41338C2 (uk) Спосіб інгібування ретровірусної інфекції, яка викликана вірусом імунодефіциту людини (віл), спосіб інгібування вірусу імунодефіциту людини (віл)
ES2128322T3 (es) Peptidos que bloquean las infecciones debidas al virus de la inmunodeficiencia humana y procedimientos de utilizacion de estos peptidos.
ES2073286T3 (es) Productos cosmeticos estables.
ATE255417T1 (de) Verwendung von bradykinin-antagonisten zur behandlung von viruserkrankungen
ES2062266T3 (es) Uso de quinolil- e isoquinoliloxazol-2-onas para la obtencion de un medicamento destinado para la prevencion de infecciones por virus envueltos por glicoproteinas.
ES2068739A1 (es) Inhibidores retrovirables de proteasas.
HUP9904189A2 (hu) Eténtartalmú oldatok fertőzések elleni terápiás és profilaktikus alkalmazásra
RU93046287A (ru) Аминодиольные ингибиторы протеза

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties